• MDxHealth will hold an extraordinary shareholders' meeting in Ghent, Belgium, on November 19, 2026.
• Shareholders will vote on a reverse stock split ranging from 1-for-5 to 1-for-30.
• The proposal gives the board six months to determine the final ratio and implement the consolidation, without changing share capital.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MDxHealth SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-114400), on October 30, 2026, and is solely responsible for the information contained therein.